Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy.

van Diepen S, Newby LK, Lopes RD, Stebbins A, Hasselblad V, James S, Roe MT, Ezekowitz JA, Moliterno DJ, Neumann FJ, Reist C, Mahaffey KW, Hochman JS, Hamm CW, Armstrong PW, Granger CB, Theroux P; APEX AMI Investigators.

Int J Cardiol. 2013 Oct 3;168(3):2127-33. doi: 10.1016/j.ijcard.2013.01.004. Epub 2013 Feb 8.

PMID:
23394896
2.

Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.

Mahaffey KW, Wampole JL, Stebbins A, Berdan LG, McAfee D, Rorick TL, French JK, Kleiman NS, O'Connor CM, Cohen EA, Granger CB, Armstrong PW; APEX-AMI Investigators.

Contemp Clin Trials. 2011 Mar;32(2):178-87. doi: 10.1016/j.cct.2010.12.013. Epub 2011 Jan 8.

PMID:
21220052
3.

Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Tjandrawidjaja MC, Fu Y, Westerhout CM, Wagner GS, Granger CB, Armstrong PW; APEX-AMI Investigators.

Am J Cardiol. 2010 Sep 1;106(5):630-4. doi: 10.1016/j.amjcard.2010.04.013.

PMID:
20723636
4.

Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.

Toma M, Buller CE, Westerhout CM, Fu Y, O'Neill WW, Holmes DR Jr, Hamm CW, Granger CB, Armstrong PW; APEX-AMI Investigators.

Eur Heart J. 2010 Jul;31(14):1701-7. doi: 10.1093/eurheartj/ehq129. Epub 2010 Jun 8.

PMID:
20530505
5.

Do baseline atrial electrocardiographic and infarction patterns predict new-onset atrial fibrillation after ST-elevation myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial.

van Diepen S, Siha H, Fu Y, Westerhout CM, Lopes RD, Granger CB, Armstrong PW; APEX AMI Investigators.

J Electrocardiol. 2010 Jul-Aug;43(4):351-8. doi: 10.1016/j.jelectrocard.2010.04.001. Epub 2010 May 4.

PMID:
20444469
6.
7.

Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

Welsh RC, Granger CB, Westerhout CM, Blankenship JC, Holmes DR Jr, O'Neill WW, Hamm CW, Van de Werf F, Armstrong PW; APEX AMI Investigators.

JACC Cardiovasc Interv. 2010 Mar;3(3):343-51. doi: 10.1016/j.jcin.2009.12.008.

8.

Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarction.

Tjandrawidjaja MC, Fu Y, Westerhout CM, White HD, Todaro TG, Van de Werf F, Mahaffey KW, Wagner GS, Granger CB, Armstrong PW; APEX-AMI Investigators.

Eur Heart J. 2010 Mar;31(5):573-81. doi: 10.1093/eurheartj/ehp494. Epub 2009 Dec 1.

PMID:
19952006
9.

Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.

Brener SJ, Westerhout CM, Fu Y, Todaro TG, Moliterno DJ, Wagner GS, Granger CB, Armstrong PW; APEX-AMI Investigators.

Am Heart J. 2009 Nov;158(5):755-60. doi: 10.1016/j.ahj.2009.09.009. Epub 2009 Oct 3.

PMID:
19853693
10.

Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

Jolicoeur EM, O'Neill WW, Hellkamp A, Hamm CW, Holmes DR Jr, Al-Khalidi HR, Patel MR, Van de Werf FJ, Pieper K, Armstrong PW, Granger CB; APEX-AMI Investigators.

Eur Heart J. 2009 Nov;30(21):2575-83. doi: 10.1093/eurheartj/ehp279. Epub 2009 Jul 11.

PMID:
19596659
11.

Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?

Bainey KR, Fu Y, Granger CB, Hamm CW, Holmes DR Jr, O'Neill WW, Seabra-Gomes R, Pfisterer ME, Van de Werf F, Armstrong PW; APEX AMI Investigators.

Heart. 2009 Aug;95(16):1331-6. doi: 10.1136/hrt.2008.160390. Epub 2009 May 15.

PMID:
19447835
12.

Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention.

Mehta RH, Starr AZ, Lopes RD, Hochman JS, Widimsky P, Pieper KS, Armstrong PW, Granger CB; APEX AMI Investigators.

JAMA. 2009 May 6;301(17):1779-89. doi: 10.1001/jama.2009.600.

PMID:
19417195
13.

Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).

Patel MR, Pfisterer ME, Betriu A, Widmisky P, Holmes DR Jr, O'Neill WW, Stebbins A, Van de Werf F, Armstrong PW, Granger CB; APEX-AMI Investigators.

Am J Cardiol. 2009 Jan 15;103(2):181-6. doi: 10.1016/j.amjcard.2008.08.066. Epub 2008 Nov 7.

PMID:
19121433
14.

Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study.

Brener SJ, Moliterno DJ, Aylward PE, van't Hof AW, Ru┼║yllo W, O'Neill WW, Hamm CW, Westerhout CM, Granger CB, Armstrong PW; APEX-AMI Investigators.

Eur Heart J. 2008 May;29(9):1127-35. doi: 10.1093/eurheartj/ehn125. Epub 2008 Mar 27.

PMID:
18375399
15.

Failure of investigator adherence to electrocardiographic entry criteria is frequent and influences clinical outcomes: lessons from APEX-AMI.

Tjandrawidjaja MC, Fu Y, Al-Khalidi H, Todaro TG, Adams P, Van de Werf F, Granger CB, Armstrong PW; APEX-AMI Investigators.

Eur Heart J. 2007 Dec;28(23):2850-7. Epub 2007 Oct 29.

PMID:
17967823
16.

Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial.

APEX AMI Investigators, Armstrong PW, Granger CB, Adams PX, Hamm C, Holmes D Jr, O'Neill WW, Todaro TG, Vahanian A, Van de Werf F.

JAMA. 2007 Jan 3;297(1):43-51.

PMID:
17200474

Supplemental Content

Loading ...
Support Center